ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

Mail Mixup Delays July 23 Issue

August 6, 1976

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991